
News from Conventus Law
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Conventus Law News

Europe · GermanyBioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy candidates. Analysts say the M&A deal is a way to essentially settle out of court the ongoing mRNA patent dispute between the companies following some recent CureVac legal wins. The post BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute appeared first on MedCity News.See the Story
BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute
47% Center coverage: 28 sources

Asia · PhilippinesCommission on Elections. File photo MANILA, Philippines — The Commission on Elections (Comelec) on Monday said it will file a motion for reconsideration before the Supreme Court to clarify the implications of its new ruling which stated that second placers in local elections cannot be proclaimed winner if the first placer has been disqualified. In its ruling made public Sunday, the Supreme Court effectively discarded the earlier Jalosjos vs. Com…See the Story
Comelec to File Motion for Reconsideration on SC Ruling on 2nd Placers
75% Left coverage: 4 sources